首页>
外国专利>
Use of leflunomide to control and reverse chronic allograft rejection and to prevent or control xenograft rejection
Use of leflunomide to control and reverse chronic allograft rejection and to prevent or control xenograft rejection
展开▼
机译:来氟米特用于控制和逆转慢性同种异体移植排斥反应以及预防或控制异种异体移植排斥反应的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to methods of controlling or reversing chronic rejection of allografts in a transplantation patient by administering leflunomide product alone, or in combination with one or more immunosuppressive agents selected from the group consisting of Cyclosporine A, FK506, rapamycin and corticosteroids. The invention also relates to methods of preventing or controlling acute and chronic rejection of xenografts in a transplantation patient by administering leflunomide product alone, or in combination with one or more immunosuppressive agents selected from the group consisting of Cyclosporine A, FK506, rapamycin and corticosteroids.
展开▼